Cargando…
EBV Promotes Human CD8(+) NKT Cell Development
The reports on the origin of human CD8(+) Vα24(+) T-cell receptor (TCR) natural killer T (NKT) cells are controversial. The underlying mechanism that controls human CD4 versus CD8 NKT cell development is not well-characterized. In the present study, we have studied total 177 eligible patients and su...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873918/ https://www.ncbi.nlm.nih.gov/pubmed/20502687 http://dx.doi.org/10.1371/journal.ppat.1000915 |
_version_ | 1782181412596613120 |
---|---|
author | Yuling, He Ruijing, Xiao Xiang, Ji Li, Li Lang, Chen Jie, Xiong Wei, Xiao Yujuan, Wang Lijun, Zhang Rui, Zhou Xinti, Tan Yongyi, Bi Yan-Ping, Jiang Youxin, Jin Jinquan, Tan |
author_facet | Yuling, He Ruijing, Xiao Xiang, Ji Li, Li Lang, Chen Jie, Xiong Wei, Xiao Yujuan, Wang Lijun, Zhang Rui, Zhou Xinti, Tan Yongyi, Bi Yan-Ping, Jiang Youxin, Jin Jinquan, Tan |
author_sort | Yuling, He |
collection | PubMed |
description | The reports on the origin of human CD8(+) Vα24(+) T-cell receptor (TCR) natural killer T (NKT) cells are controversial. The underlying mechanism that controls human CD4 versus CD8 NKT cell development is not well-characterized. In the present study, we have studied total 177 eligible patients and subjects including 128 healthy latent Epstein-Barr-virus(EBV)-infected subjects, 17 newly-onset acute infectious mononucleosis patients, 16 newly-diagnosed EBV-associated Hodgkin lymphoma patients, and 16 EBV-negative normal control subjects. We have established human-thymus/liver-SCID chimera, reaggregated thymic organ culture, and fetal thymic organ culture. We here show that the average frequency of total and CD8(+) NKT cells in PBMCs from 128 healthy latent EBV-infected subjects is significantly higher than in 17 acute EBV infectious mononucleosis patients, 16 EBV-associated Hodgkin lymphoma patients, and 16 EBV-negative normal control subjects. However, the frequency of total and CD8(+) NKT cells is remarkably increased in the acute EBV infectious mononucleosis patients at year 1 post-onset. EBV-challenge promotes CD8(+) NKT cell development in the thymus of human-thymus/liver-SCID chimeras. The frequency of total (3% of thymic cells) and CD8(+) NKT cells (∼25% of NKT cells) is significantly increased in EBV-challenged chimeras, compared to those in the unchallenged chimeras (<0.01% of thymic cells, CD8(+) NKT cells undetectable, respectively). The EBV-induced increase in thymic NKT cells is also reflected in the periphery, where there is an increase in total and CD8(+) NKT cells in liver and peripheral blood in EBV-challenged chimeras. EBV-induced thymic CD8(+) NKT cells display an activated memory phenotype (CD69(+)CD45RO(hi)CD161(+)CD62L(lo)). After EBV-challenge, a proportion of NKT precursors diverges from DP thymocytes, develops and differentiates into mature CD8(+) NKT cells in thymus in EBV-challenged human-thymus/liver-SCID chimeras or reaggregated thymic organ cultures. Thymic antigen-presenting EBV-infected dendritic cells are required for this process. IL-7, produced mainly by thymic dendritic cells, is a major and essential factor for CD8(+) NKT cell differentiation in EBV-challenged human-thymus/liver-SCID chimeras and fetal thymic organ cultures. Additionally, these EBV-induced CD8(+) NKT cells produce remarkably more perforin than that in counterpart CD4(+) NKT cells, and predominately express CD8αα homodimer in their co-receptor. Thus, upon interaction with certain viruses, CD8 lineage-specific NKT cells are developed, differentiated and matured intrathymically, a finding with potential therapeutic importance against viral infections and tumors. |
format | Text |
id | pubmed-2873918 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-28739182010-05-25 EBV Promotes Human CD8(+) NKT Cell Development Yuling, He Ruijing, Xiao Xiang, Ji Li, Li Lang, Chen Jie, Xiong Wei, Xiao Yujuan, Wang Lijun, Zhang Rui, Zhou Xinti, Tan Yongyi, Bi Yan-Ping, Jiang Youxin, Jin Jinquan, Tan PLoS Pathog Research Article The reports on the origin of human CD8(+) Vα24(+) T-cell receptor (TCR) natural killer T (NKT) cells are controversial. The underlying mechanism that controls human CD4 versus CD8 NKT cell development is not well-characterized. In the present study, we have studied total 177 eligible patients and subjects including 128 healthy latent Epstein-Barr-virus(EBV)-infected subjects, 17 newly-onset acute infectious mononucleosis patients, 16 newly-diagnosed EBV-associated Hodgkin lymphoma patients, and 16 EBV-negative normal control subjects. We have established human-thymus/liver-SCID chimera, reaggregated thymic organ culture, and fetal thymic organ culture. We here show that the average frequency of total and CD8(+) NKT cells in PBMCs from 128 healthy latent EBV-infected subjects is significantly higher than in 17 acute EBV infectious mononucleosis patients, 16 EBV-associated Hodgkin lymphoma patients, and 16 EBV-negative normal control subjects. However, the frequency of total and CD8(+) NKT cells is remarkably increased in the acute EBV infectious mononucleosis patients at year 1 post-onset. EBV-challenge promotes CD8(+) NKT cell development in the thymus of human-thymus/liver-SCID chimeras. The frequency of total (3% of thymic cells) and CD8(+) NKT cells (∼25% of NKT cells) is significantly increased in EBV-challenged chimeras, compared to those in the unchallenged chimeras (<0.01% of thymic cells, CD8(+) NKT cells undetectable, respectively). The EBV-induced increase in thymic NKT cells is also reflected in the periphery, where there is an increase in total and CD8(+) NKT cells in liver and peripheral blood in EBV-challenged chimeras. EBV-induced thymic CD8(+) NKT cells display an activated memory phenotype (CD69(+)CD45RO(hi)CD161(+)CD62L(lo)). After EBV-challenge, a proportion of NKT precursors diverges from DP thymocytes, develops and differentiates into mature CD8(+) NKT cells in thymus in EBV-challenged human-thymus/liver-SCID chimeras or reaggregated thymic organ cultures. Thymic antigen-presenting EBV-infected dendritic cells are required for this process. IL-7, produced mainly by thymic dendritic cells, is a major and essential factor for CD8(+) NKT cell differentiation in EBV-challenged human-thymus/liver-SCID chimeras and fetal thymic organ cultures. Additionally, these EBV-induced CD8(+) NKT cells produce remarkably more perforin than that in counterpart CD4(+) NKT cells, and predominately express CD8αα homodimer in their co-receptor. Thus, upon interaction with certain viruses, CD8 lineage-specific NKT cells are developed, differentiated and matured intrathymically, a finding with potential therapeutic importance against viral infections and tumors. Public Library of Science 2010-05-20 /pmc/articles/PMC2873918/ /pubmed/20502687 http://dx.doi.org/10.1371/journal.ppat.1000915 Text en Yuling et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Yuling, He Ruijing, Xiao Xiang, Ji Li, Li Lang, Chen Jie, Xiong Wei, Xiao Yujuan, Wang Lijun, Zhang Rui, Zhou Xinti, Tan Yongyi, Bi Yan-Ping, Jiang Youxin, Jin Jinquan, Tan EBV Promotes Human CD8(+) NKT Cell Development |
title | EBV Promotes Human CD8(+) NKT Cell Development |
title_full | EBV Promotes Human CD8(+) NKT Cell Development |
title_fullStr | EBV Promotes Human CD8(+) NKT Cell Development |
title_full_unstemmed | EBV Promotes Human CD8(+) NKT Cell Development |
title_short | EBV Promotes Human CD8(+) NKT Cell Development |
title_sort | ebv promotes human cd8(+) nkt cell development |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873918/ https://www.ncbi.nlm.nih.gov/pubmed/20502687 http://dx.doi.org/10.1371/journal.ppat.1000915 |
work_keys_str_mv | AT yulinghe ebvpromoteshumancd8nktcelldevelopment AT ruijingxiao ebvpromoteshumancd8nktcelldevelopment AT xiangji ebvpromoteshumancd8nktcelldevelopment AT lili ebvpromoteshumancd8nktcelldevelopment AT langchen ebvpromoteshumancd8nktcelldevelopment AT jiexiong ebvpromoteshumancd8nktcelldevelopment AT weixiao ebvpromoteshumancd8nktcelldevelopment AT yujuanwang ebvpromoteshumancd8nktcelldevelopment AT lijunzhang ebvpromoteshumancd8nktcelldevelopment AT ruizhou ebvpromoteshumancd8nktcelldevelopment AT xintitan ebvpromoteshumancd8nktcelldevelopment AT yongyibi ebvpromoteshumancd8nktcelldevelopment AT yanpingjiang ebvpromoteshumancd8nktcelldevelopment AT youxinjin ebvpromoteshumancd8nktcelldevelopment AT jinquantan ebvpromoteshumancd8nktcelldevelopment |